From this observation we can infer that high levels of HDAC4 mediated by miR-22 down-regulation could be involved in the reduced TH17 response found in patients with COPD-BS, leading to a lower inflammatory response and a decrease in emphysema, in comparison with patients with COPD-TS. This evidence concerns the gene HDAC4 and pulmonary emphysema.